Search

Stilnox CR

Stilnox CR

zolpidem

Manufacturer:

Sanofi

Distributor:

DCH Auriga - Healthcare
/
Four Star
Concise Prescribing Info
Contents
Zolpidem tartrate
Indications/Uses
Short-term treatment of insomnia in adults.
Click to view Stilnox CR detailed prescribing information
Dosage/Direction for Use
Should be taken immediately before bedtime. Max treatment duration: 4 wk. Adult 12.5 mg daily. Elderly, debilitated & hepatically impaired patients 6.25 mg daily.
Click to view Stilnox CR detailed prescribing information
Overdosage
View Stilnox CR overdosage for action to be taken in the event of an overdose.
Administration
Should be taken on an empty stomach: Swallow whole, do not divide/chew/crush.
Contraindications
Hypersensitivity. Sleep apnoea; myasthenia gravis; acute &/or severe pulmonary insufficiency. Prior or concomitant intake w/ alcohol. Severe hepatic insufficiency. Patients who have previously experienced complex sleep behaviours after taking Stilnox CR. Childn <18 yr.
Click to view Stilnox CR detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Stilnox CR detailed prescribing information
Special Precautions
Risk of tolerance, abuse &/or physical & psychological dependence upon prolonged use; rebound insomnia upon w/drawal; drowsiness & decreased level of consciousness; suicide & suicide attempts; psychiatric & paradoxical reactions; somnambulism & associated behaviours; psychomotor impairment. Patients w/ known congenital long QT syndrome; resp insufficiency; psychotic illness including depression, psychosis, schizophrenia; addiction; epilepsy; renal or hepatic impairment; elderly or debilitated patients. May induce anterograde amnesia. Do not rechallenge in patients who develop angioedema after treatment. Concomitant use w/ opioids may result in sedation, resp depression, coma & death. Avoid driving or operating machinery for 8 hr after taking Stilnox CR. Not recommended during pregnancy & lactation.
Click to view Stilnox CR detailed prescribing information
Adverse Reactions
Drowsiness, dizziness, diarrhoea, drugged feeling, headache, somnolence.
Click to view Stilnox CR detailed prescribing information
Drug Interactions
Additive central depressant effect w/ CNS depressants eg, alcohol, benzodiazepines, barbiturates, sedative/hypnotics, anxiolytics, antidepressant agents (including TCAs, MAOIs), antipsychotics (neuroleptics), phenothiazines, skeletal muscle relaxants, antihistamines, neuroleptics, antiepileptic drugs, narcotic analgesics or anaesth; opioids. Euphoric enhancement w/ narcotic analgesics. Increased risk of somnambulism & associated behaviours w/ alcohol & other CNS depressants. Additive sedative effects w/ imipramine. Decreased alertness & psychomotor performance w/ chlorpromazine. Decreased pharmacodynamic effect w/ CYP3A4 inducers (eg, rifampicin & St. John's Wort). Enhanced sedative effects w/ ketoconazole (CYP3A4 inhibitor). Increased blood levels w/ fluvoxamine (strong CYP1A2 inhibitor & moderate to weak CYP2C9 & CYP3A4 inhibitor); ciprofloxacin (moderate CYP1A2 & CYP3A4 inhibitor).
Click to view Stilnox CR detailed prescribing information
Description
View Stilnox CR description for details of the chemical structure and excipients (inactive components).
Action
View Stilnox CR mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Hypnotics & Sedatives
ATC Classification
N05CF02 - zolpidem ; Belongs to the class of benzodiazepine related agents. Used as hypnotics and sedatives.
Presentation/Packing
Form
Stilnox CR modified-release tab 12.5 mg
Packing/Price
14's
Form
Stilnox CR modified-release tab 6.25 mg
Packing/Price
14's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in